what to expect from bpc 157 Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157 Peptide Therapy | New

Doses of 0.125mg (2.5 units at 5mg/ml) or even 0.0625mg (1.25 units) fall well below the standard starting dose but have anecdotal support in some communities

Nausea is the primary side effect and is dose-dependent

A 2021 study published in Biomedicines it demonstrated that BPC-157 significantly improved tendon healing in rats by promoting angiogenesis and collagen synthesis, leading to faster functional recovery (Sikiric et al., 2021)

Resuming protocols if symptoms return remains an option

This molecular architecture gives the peptide exceptional stability, allowing it to remain active in harsh environments like stomach acid for over 24 hours